In conclusion, our studies demonstrated that BM-MSC can modulate sepsis-induced inflammation through mTORC1-S6K and mTORC2-Akt pathway, alleviating sepsis-induced cardiac dysfunction. Here, RPS6KB1 is linked to Sepsis.